Nurse empowerment through Pharmacogenetics

Nurse empowerment through Pharmacogenetics

Objective: to verify the existence of elements that justify the use of pharmacogenetics by the Brazilian nurse. Method: this is a quantitative, cross-sectional, observational, descriptive study, whose final sample was 67 individuals. The participants were healthy at the time of the study and report...

Full description

Bibliographic Details
Main Authors:	Jordana Carvalhaes de Moraes, Fernanda Daniela Dornelas Nunes, Fernanda Borchers Coeli-Lacchini, Anderson Heiji Lima Miyazaki, Milena Flória-Santos, Riccardo Lacchini
Format:	Article
Language:	English
Published:	Universidade de São Paulo
Series:	Revista Latino-Americana de Enfermagem
Subjects:	Cytochrome P-450 CYP2C9 Pharmacogenetics Drug-Related Side Effects Adverse Reactions Nursing Nursing Process
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0104-11692020000100377&tlng=pt

Similar Items

Association of CYP2C9*2 Allele with Sulphonylurea-Induced Hypoglycaemia in Type 2 Diabetes Mellitus Patients: A Pharmacogenetic Study in Pakistani Pashtun Population
by: Asif Jan, et al.
Published: (2023-08-01)

Pharmacogenetics in Psychiatry: An Update on Clinical Usability
by: Ron H. N. van Schaik, et al.
Published: (2020-09-01)

Policy and Practice Review: A First Guideline on the Use of Pharmacogenetics in Clinical Psychiatric Practice
by: R. van Westrhenen, et al.
Published: (2021-04-01)

Cases of Adverse Reaction to Psychotropic Drugs and Possible Association with Pharmacogenetics
by: Irina Piatkov, et al.
Published: (2012-10-01)

Pharmacogenetics of Lethal Opioid Overdose: Review of Current Evidence and Preliminary Results from a Pilot Study
by: Leen Magarbeh, et al.
Published: (2023-05-01)

Pharmacogenetic Dose Modeling Based on CYP2C19 Allelic Phenotypes
by: Julia Carolin Stingl, et al.
Published: (2022-12-01)

Genetic polymorphisms of CYP3A5, CHRM2, and ZNF498 and their association with epilepsy susceptibility: a pharmacogenetic and case–control study
by: AL-Eitan LN, et al.
Published: (2019-09-01)

Pharmacogenetics of schizophrenia in real clinical practice: a clinical case
by: R. F. Nasyrova, et al.
Published: (2018-12-01)

Variability Between Clinical Pharmacogenetics Implementation Consortium (CPIC®) Guidelines and a Commercial Pharmacogenetics Laboratory in Genotype to Phenotype Interpretations For Patients Utilizing Psychotropics
by: Christopher Blazy, et al.
Published: (2022-06-01)

Genotype-guided versus traditional clinical dosing of warfarin in patients of Asian ancestry: a randomized controlled trial
by: Nicholas L. Syn, et al.
Published: (2018-07-01)

Implementation of Pharmacogenetics in First-Line Care: Evaluation of Its Use by General Practitioners
by: Denise van der Drift, et al.
Published: (2023-09-01)

CYP2D6 Genotype-Based Dose Recommendations for Risperidone in Asian People
by: Yuanxia Cui, et al.
Published: (2020-08-01)

Analysis of the complications of endocrine therapy with tamoxifen in breast cancer: clinical and pharmacogenetic aspects. Prospective pharmacogenetic cohort study
by: Marina I. Savelyeva, et al.
Published: (2022-11-01)

Pharmacogenetics of Praziquantel Metabolism: Evaluating the Cytochrome P450 Genes of Zimbabwean Patients During a Schistosomiasis Treatment
by: Grace Zdesenko, et al.
Published: (2022-06-01)

Knowledge and Attitudes of Pharmacogenetics Among Canadian Nurses: Implications for Nursing Education
by: Noopur Swadas, et al.
Published: (2022-06-01)

Analysis of CYP3A4*1B and CYP3A5*3 polymorphisms in population of Bosnia and Herzegovina
by: Sabina Semiz, et al.
Published: (2011-02-01)

The Effect of Polymorphisms in the CYP2D6 and CYP2C9 Genes on the Clinical Efficacy of Tramadol and Ketorolac When Using the Accelerated Recovery Protocol in Patients With Uncomplicated Acute Calculous Cholecystitis Who Underwent Cholecystectomy
by: A. A. Muradyan, et al.
Published: (2020-10-01)

Pharmacogenetics and drug-induced nephrotoxicity in renal transplant recipients
by: Sepideh Zununi Vahed, et al.
Published: (2015-02-01)

Pharmacogenetics of antiepileptic drugs (literature review)
by: E. . Bochanova
Published: (2018-05-01)

Case report: application of pharmacogenetics in the personalized treatment of an elderly patient with a major depressive episode
by: Milica Pjevac, et al.
Published: (2023-08-01)

A Robust and Fast/Multiplex Pharmacogenetics Assay to Simultaneously Analyze 17 Clinically Relevant Genetic Polymorphisms in <i>CYP3A4</i>, <i>CYP3A5</i>, <i>CYP1A2</i>, <i>CYP2C9</i>, <i>CYP2C19</i>, <i>CYP2D6</i>, <i>ABCB1,</i> and <i>VKORC1</i> Genes
by: Camille Tron, et al.
Published: (2022-05-01)

Pharmacogenetics of Drug Metabolism: The Role of Gene Polymorphism in the Regulation of Doxorubicin Safety and Efficacy
by: Alina A. Bagdasaryan, et al.
Published: (2022-11-01)

Practice of CYP450 genotyping and phenotyping in children in a real-life setting
by: Frédérique Rodieux, et al.
Published: (2023-02-01)

Impact of Pomegranate Juice on the Pharmacokinetics of CYP3A4- and CYP2C9-Mediated Drugs Metabolism: A Preclinical and Clinical Review
by: Kenza Mansoor, et al.
Published: (2023-02-01)

CYP2C9 Variations and Their Pharmacogenetic Implications Among Diverse South Asian Populations
by: Nizamuddin S, et al.
Published: (2021-01-01)

Genetic variability of CYP2D6, CYP2B6, CYP2C9 and CYP2C19 genes across the Italian Peninsula
by: Francesco Carano, et al.
Published: (2018-01-01)

Pharmacogenomics of cytochrome P450 3A4 (CYP3A4): recent progress towards the missing heritability problem
by: Kathrin eKlein, et al.
Published: (2013-02-01)

Multi-Ethnic Analysis of Cardiac Pharmacogenetic Markers of Cytochrome P450 and Membrane Transporters Genes in the Russian Population
by: K. B. Mirzaev, et al.
Published: (2019-07-01)

Pharmacogenetics of the safety of phenazepam in alcohol withdrawal syndrome: haplotype and combinatorial analyses of polymorphic variants in the pharmacokinetic factor genes
by: D. V. Ivashchenko, et al.
Published: (2020-04-01)

Clinical Relevance of a 16-Gene Pharmacogenetic Panel Test for Medication Management in a Cohort of 135 Patients
by: David F. Niedrig, et al.
Published: (2021-07-01)

Pharmacogenetics and phenoconversion: the influence on side effects experienced by psychiatric patients
by: Manon G. den Uil, et al.
Published: (2023-08-01)

CYP2C19 and CYP2D6 Genotypes and Metabolizer Status Distribution in a Bulgarian Psychiatric Cohort
by: Hristo Y. Ivanov, et al.
Published: (2022-07-01)

Warfarin Pharmacogenetics: Challenges and Opportunities for Clinical Translation
by: Nita A Limdi, et al.
Published: (2012-10-01)

Utility of pharmacogenetic testing to optimise antidepressant pharmacotherapy in youth: a narrative literature review
by: Bradley Roberts, et al.
Published: (2023-09-01)

CYP2C9 polymorphisms in epilepsy: influence on phenytoin treatment
by: Silvado CE, et al.
Published: (2018-03-01)

CLOPIDOGREL PHARMACOGENETICS
by: A. N. Meshkov
Published: (2016-01-01)

Impact of amiodarone use on metoprolol concentrations, α‐OH‐metoprolol concentrations, metoprolol dosing and heart rate: A cross‐sectional study
by: Sabrina Robert, et al.
Published: (2023-10-01)

Frequency of CYP2D6 Alleles Including Structural Variants in the United States
by: Andria L. Del Tredici, et al.
Published: (2018-04-01)

Prevalence of exposure to pharmacogenetic drugs by the Saudis treated at the health care centers of the Ministry of National Guard
by: Mohammad A. Alshabeeb, et al.
Published: (2022-08-01)

The Effects of CYP2C19 Genotype on Proxies of SSRI Antidepressant Response in the UK Biobank
by: Win Lee Edwin Wong, et al.
Published: (2023-09-01)